Craig Singewald

Craig Singewald is currently the Senior Director, US Market Access Lead for Inflammation & Immunology at Pfizer, where they are responsible for the US Market Access Strategy for a diverse portfolio of products. They previously held positions at Wyeth and Cap Gemini Ernst & Young, where they developed effective business operations and strategies. Craig earned a Bachelor of Science in Business Administration from the University of Richmond, an MBA in Health Sector Management from Duke University, and an MS in Engineering Management from the University of Bridgeport. Their extensive experience spans roles in sales operations, project coordination, and global marketing.